Danaher Corp is primarily active in the industrial and healthcare sectors.

The main competitors of Danaher Corp in the market are Thermo Fisher Scientific Inc., Agilent Technologies Inc., and PerkinElmer, Inc.

Danaher Corp, founded in 1969, is a globally recognized company specializing in science and technology solutions. Initially an environmental testing equipment manufacturer, it has since diversified its portfolio into healthcare, industrial, and consumer sectors. With a strong emphasis on innovation, Danaher has continually expanded through strategic acquisitions, fostering growth and enhancing its capabilities. The company's commitment to operational excellence has earned it a reputation for delivering high-quality products and services across its various business segments. Over the years, Danaher Corp has established itself as a leading force in the global market, driving advancements in diagnostics, life sciences, dental care, and water quality.

Danaher Corp has achieved several significant milestones throughout its history. The company's successful acquisition of various businesses and subsequent integration has greatly expanded its product portfolio and global presence. In 1984, Danaher implemented the highly regarded Danaher Business System (DBS), a continuous improvement methodology that has driven operational excellence across its businesses. In 2016, the company completed the acquisition of Pall Corporation, a global leader in filtration, separation, and purification technologies, further strengthening its position in the life sciences and diagnostics market. The following year, Danaher completed the spin-off of its industrial business into Fortive Corporation, allowing both entities to focus on their respective growth opportunities. These milestones reflect Danaher Corp's commitment to strategic growth and delivering value to its shareholders.

Danaher Corp is primarily present in multiple countries and regions worldwide. As a multinational conglomerate, the company has a wide geographic footprint. Danaher Corp operates across various countries, including the United States, Canada, Mexico, Brazil, Argentina, Chile, Germany, France, the United Kingdom, Spain, Italy, Russia, China, Japan, India, Australia, and many more. With its global presence, Danaher Corp has established itself as a leading player in multiple industries, including life sciences, diagnostics, dental, and environmental and applied solutions.

Danaher Corp is a leading global science and technology innovator committed to improving the quality of life. The company's corporate philosophy revolves around continuous improvement and leveraging their strong portfolio of businesses to drive growth and create long-term value for shareholders. With a focus on innovation, Danaher Corp places high importance on developing cutting-edge solutions across various industries, including diagnostics, life sciences, dental, environmental, and industrial markets. By emphasizing customer-centricity and operational excellence, Danaher Corp aims to provide superior products and services that address critical challenges and improve outcomes for customers worldwide.

Analysts currently set an average price target of 268.83 USD for the Danaher stock (median: 272.85 USD), implying +30.6 % versus the latest price. The consensus is based on 31 analyst ratings.

Danaher Analyst Price Targets 2026

31 analysts currently rate the Danaher stock: 27 recommend buying, 4 holding and 0 selling. For 2026, analysts expect Danaher to generate revenue of 26.12 B USD and earnings per share of 8.54 USD.

Danaher Analyst Price Targets 2026

Converted at the current exchange rate, the Danaher share trades at 176.38 EUR (203.40 USD).

The Danaher share (DHR) is listed on 10 stock exchanges, including: NYSE (DHR), XETRA (DAP.DE), Frankfurt (DAP.F), München (DAP.MU), Düsseldorf (DAP.DU), London (0R2B.L), London (0R2B.L), SIX (Zürich) (DHR.SW).

The Danaher Corporation is a diversified business model with a portfolio of strategically aligned business sectors. The company develops, manufactures, and sells a variety of precision instruments and systems, as well as products and services for various applications in healthcare, environment, industry, and technology research. The key business sectors include Life Sciences, Diagnostics, Dental, Environmental & Applied Solutions, Agilent Technologies, and Pall Corporation. These divisions offer a wide range of products and services, such as medical diagnostic systems, dental instruments, environmental and water analysis devices, laboratory technologies, tools and materials for electronics manufacturing, as well as consumables and accessories for the life sciences field. Danaher also has a broad range of brands, including Cepheid, Leica Microsystems, Beckman Coulter, Hach, Esko, KaVo Kerr, ChemTreat, IDBS, Keithley, and Tektronix. These brands are leaders in their respective industries, with strong market positions and established customer bases. An important part of Danaher's business model is its management system, based on the Danaher Business System (DBS). This is a process of continuous improvement that enhances the company's efficiency and productivity. DBS is a combination of Lean Manufacturing, Six Sigma, and other innovation techniques, and has proven successful in streamlining business processes, reducing costs, and improving overall company performance. The company also has a strong global presence, with an extensive network of sales and service centers in North America, Europe, Asia, and other regions worldwide. Danaher generates a significant portion of its revenue outside the US and benefits from growing demand in emerging markets. The company also invests in research and development to develop innovative products and solutions that meet the needs of its customers. Overall, Danaher's business model is well-positioned for success in various industries and on a global scale, thanks to its diversified product range, brands, and management process. The company has proven itself by providing tailored solutions to meet its customers' needs and consistently executing its growth strategies.

The expected revenue of Danaher is 26.12 B USD. This figure is based on current financial data and reflects the company's business performance.

The expected profit of Danaher is 6.07 B USD. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Danaher is currently 23.81. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Danaher stock.

The price-to-sales ratio (P/S) of Danaher is currently 5.54. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Danaher stock.

The Eulerpool Quality Score for Danaher is 5/10.

The ISIN of Danaher is US2358511028. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of Danaher is 866197. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of Danaher is DHR. The ticker symbol is used to trade Danaher shares on the stock exchange.

Over the past 12 months, Danaher paid a dividend of 1.28 USD . This corresponds to a dividend yield of about 0.63 %. For the coming 12 months, Danaher is expected to pay a dividend of 1.80 USD.

The current dividend yield of Danaher is 0.63 %.

Danaher pays a dividend, distributed in the months of , , , .

Danaher paid dividends every year for the past 33 years.

For the upcoming 12 months, dividends amounting to 1.80 USD are expected. This corresponds to a dividend yield of 0.87 %.

Danaher is assigned to the 'Health' sector.

In the year 2025, Danaher distributed 1.08 USD as dividends.

The dividends of Danaher are distributed in USD.